Clinical response to discontinuation of anti-TNF therapy in patients with ankylosing spondylitis after 3 years of continuous treatment with infliximab

We analyzed the clinical response and the time to relapse after discontinuation of continuous long-term infliximab therapy in patients with ankylosing spondylitis (AS). After 3 years of infliximab therapy, all AS patients (n = 42) discontinued treatment (time point (TP)1) and were visited regularly...

Deskribapen osoa

Gorde:
Xehetasun bibliografikoak
Egile Nagusiak: Baraliakos, Xenofon, Listing, Joachim, Brandt, Jan, Rudwaleit, Martin, Sieper, Joachim, Braun, Juergen
Formatua: Artigo
Hizkuntza:Inglês
Argitaratua: BioMed Central 2005
Gaiak:
Research Article
Sarrera elektronikoa:https://ncbi.nlm.nih.gov/pmc/articles/PMC1174938/
https://ncbi.nlm.nih.gov/pubmed/15899030
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/ar1693
Etiketak: Etiketa erantsi
Etiketarik gabe, Izan zaitez lehena erregistro honi etiketa jartzen!

Antzeko izenburuak